Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjusted Carboplatin Dosing (CARBMI)
NCT02103244Phase 4Unknown
- Sponsor
- Rijnstate
- Start
- Sep 2014
- Primary completion
- Sep 2015
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 4 trial of carboplatin in non-small cell lung cancer (NSCLC), small cell lung cancer (SCLC), ovarian cancer, sponsored by Rijnstate. Status: unknown.
02
Drugs
carboplatin
03
Conditions
non-small cell lung cancer (NSCLC)small cell lung cancer (SCLC)ovarian cancer
Beyond the preview
Go deeper on NCT02103244.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02103244.